LTBR at a glance
LIGHTBRIDGE Corp (LTBR, SEC CIK 1084554) filed its latest 10-K annual report on February 26, 2026, a 10-Q quarterly report on November 4, 2026, an 8-K current report on November 2, 2026 and Form 4 insider filings as recently as November 20, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.
- For the fiscal year ended December 31, 2025 (FY2025), LIGHTBRIDGE Corp (LTBR) reported revenue of $0 and a net loss of $19.6 million.
- As of September 30, 2026, 23 institutional investment managers tracked by SignalX reported holding LIGHTBRIDGE Corp (LTBR) shares worth $49.4 million in 13F-HR filings.
- The most recent insider open-market sale reported on Form 4 was by Goodman Sherri on October 1, 2026 of 1,116 shares at $6.29 per share.
- In the last 90 days, LTBR insiders reported 0 open-market purchases ($0) and 2 open-market sales ($12K) on Form 4, a net sale of $12K.
Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).
- Revenue · FY2025
- $0
- 10-K XBRL
- Insiders · 90 days
- 0 buys · 2 sells
- Net −$12K
- 13F holders
- 23 funds
- $49.4M · −1 vs prior quarter
- Latest 8-K
- Nov 2, 2026
- Item 2.02
AI 10-Q Quarterly Report Analysis
Latest 10-Q, quarter ended Sep 30, 2026
Management Discussion & Analysis
- Quarterly revenue: none reported, development-stage company
- Net loss $8.3M vs $4.1M YoY, operating expenses $10.3M vs $5.2M
- R&D highest expense at $5.3M vs $2.0M, G&A $5.0M vs $3.2M
- Cash $236.7M vs $201.9M at December 31, 2025, operating cash used $13.2M
- Pilot Factory estimated at $140M over approximately five years, additional capital expected through equity financing and partnerships
Risk Factors
- New project risk: Pilot Factory requires approximately $140 million over five years, with preliminary estimates subject to change
- Regulatory risk: DOE authorization, INL access, safety approvals and HALEU availability remain prerequisites
- Operational risk: Construction delays could defer Lightbridge Fuel qualification, manufacturing and commercial deployment
- Financial risk: Cost overruns could force earlier capital raising and dilute existing stockholders through equity financing
AI summary of the LTBR 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K
AI 8-K Current Report Analysis
The most recent material events, by 8-K item
Item 2.02: Results of Operations and Financial Condition
- Press release covers Lightbridge’s quarter ended September 30, 2026
- Exhibit 99.1 contains the company’s fiscal 2026 quarterly results
Item EX-99.1: Item EX-99.1
- Q3 FY2026 results show accelerating investment: R&D $5.3M vs $2.0M, G&A $5.0M vs $3.2M year over year
- Net loss widened to $8.3M, or $(0.23) per share, from $4.1M, or $(0.16), reflecting commercialization spending
Item EX-99.2: Item EX-99.2
- DOE selection creates an accelerated pathway to manufacture Lead Test Assemblies at INL, advancing Lightbridge toward commercial-reactor testing
- SHED facility construction could begin as soon as next year, with preliminary estimates indicating funding from current cash and financial resources
Item 7.01: Regulation FD Disclosure
- DOE selected Lightbridge for Nuclear Energy Launch Pad INL participation
- Initiative administered by DOE’s National Reactor Innovation Center at Idaho National Laboratory
Item 8.01: Other Events
- Lightbridge selected for Launch Pad, signaling participation in an external development or commercialization program
- Strategic validation may improve visibility and partnership prospects, but financial impact remains unspecified
Item EX-99.1: Item EX-99.1
- DOE Launch Pad INL selection creates a two-track commercialization pathway: SHED under DOE authorization and LEFF under NRC licensing
- Existing cash and financial resources currently expected to fund SHED construction, operation, and decommissioning
Item 8.01: Other Events
- Selection for DOE’s Nuclear Energy Launch Pad Program, administered through INL’s National Reactor Innovation Center
- Government-backed program participation enhances Lightbridge’s reactor-development validation and strategic visibility
AI summaries of LTBR 8-K current reports filed with the SEC. What 8-K item codes mean
SignalX for LTBR
Don't miss the next LTBR filing
- Alerts as it files. A push when LTBR files an 8-K or an insider trades.
- Fund moves. Which tracked funds opened, added or cut LTBR, by share count.
- Ask anything. An AI agent that reads every LTBR filing and answers with sources.
Recent Insider Transactions (Form 4)
Latest reported trades by officers, directors and 10% owners
| Insider | Type | Date | Shares | Price |
|---|---|---|---|---|
| Holcombe Scott Randall | F | Nov 20, 2026 | 4,163 | $3.23 |
| MUSHAKOV ANDREY | F | Nov 20, 2026 | 6,730 | $3.23 |
| GRAE SETH | F | Nov 20, 2026 | 10,791 | $3.23 |
| GOLDMAN LARRY | F | Nov 20, 2026 | 7,048 | $3.23 |
| Goodman Sherri | Sell | Oct 1, 2026 | 1,116 | $6.29 |
| Chakraborty Sweta | Sell | Sep 1, 2026 | 717 | $7.43 |
| Holcombe Scott Randall | F | Aug 28, 2026 | 103 | $7.55 |
| GOLDMAN LARRY | F | Aug 28, 2026 | 7,139 | $7.55 |
Financial SummaryXBRL
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Profitability | |||
| Revenue | $0 | $0 | $0 |
| Operating Income | -$9.0M | -$13.1M | -$23.2M |
| Net Income | -$7.9M | -$11.8M | -$19.6M |
| Balance Sheet | |||
| Total Assets | $29.4M | $41.0M | $203.8M |
| Equity | $28.9M | $40.5M | $203.0M |
| ROE | -27.4% | -29.1% | -9.6% |
| Per Share | |||
| EPS | $-0.65 | $-0.81 | - |
| Cash Flow | |||
| Operating CF | -$6.5M | -$9.5M | -$14.3M |
Source: XBRL data in LIGHTBRIDGE Corp (LTBR)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →
13F Fund Holdings: Quarterly Trend
Latest: Q3 2026Aggregate LTBR share value held by 13F filers tracked by SignalX, by quarter.
Quarterly totals table
| Quarter | Funds | Total value |
|---|---|---|
| Q3 2026 | 23 | $49.4M |
| Q2 2026 | 24 | $80.3M |
| Q1 2026 | 25 | $84.7M |
| Q4 2025 | 24 | $108.0M |
| Q3 2025 | 23 | $139.2M |
| Q2 2025 | 18 | $59.5M |
| Q1 2025 | 15 | $12.5M |
| Q4 2024 | 8 | $6.2M |
- Millennium Management+287.2K (+41%)
- D.E. Shaw & Co+177.8K (+107%)
- Morgan Stanley+157.6K (+175%)
- Goldman Sachs Group+127.5K (+321%)
- Renaissance Technologies LLC+117.3K (+35%)
- State Street Corp−2.10M (-74%)
- BlackRock−31.2K (-1%)
- Wells Fargo & Co−22.8K (-53%)
- AQR Capital Management−13.2K (-23%)
- Northern Trust−7.4K (-3%)
- StoneX Group Inc.+13.8K
- Two Sigma Investments−26.5K
- FMR LLC (Fidelity)−382
Source: 13F-HR filings on SEC EDGAR (aggregated from 160 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work
LTBR filing archive
AI analysis pages for each 10-K, 10-Q and 8-K
Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4
| Form | Filing date | Period | Analysis | SEC |
|---|---|---|---|---|
| 4 | Nov 20, 2026 | - | - | - |
| 4 | Nov 20, 2026 | - | - | - |
| 4 | Nov 20, 2026 | - | - | - |
| 4 | Nov 20, 2026 | - | - | - |
| 10-Q | Nov 4, 2026 | Sep 30, 2026 | Analysis | |
| 8-K | Nov 2, 2026 | - | Analysis | - |
| 4 | Oct 2, 2026 | - | - | - |
| 8-K | Sep 8, 2026 | - | Analysis | - |
| 4 | Sep 2, 2026 | - | - | - |
| 4 | Aug 28, 2026 | - | - | - |
| 4 | Aug 28, 2026 | - | - | - |
| 4 | Aug 28, 2026 | - | - | - |
| 4 | Aug 28, 2026 | - | - | - |
| 8-K | Aug 26, 2026 | - | Analysis | - |
| 4 | Aug 12, 2026 | - | - | - |
| 4 | Aug 7, 2026 | - | - | - |
| 4 | Aug 7, 2026 | - | - | - |
| 4 | Aug 7, 2026 | - | - | - |
| 8-K | Aug 7, 2026 | - | Analysis | - |
| 4 | Aug 7, 2026 | - | - | - |
| 4 | Aug 7, 2026 | - | - | - |
| SC 13G | Aug 7, 2026 | - | - | |
| 4 | Aug 7, 2026 | - | - | - |
| 4 | Aug 7, 2026 | - | - | - |
| 4 | Aug 7, 2026 | - | - | - |
Related Health Care companies
- KRO · KRONOS WORLDWIDE INCIndustrial Inorganic Chemicals
- LXU · LSB INDUSTRIES, INC.Industrial Inorganic Chemicals
- LXFR · LUXFER HOLDINGS PLCIndustrial Inorganic Chemicals
- NL · NL INDUSTRIES INCIndustrial Inorganic Chemicals
- TROX · Tronox Holdings plcIndustrial Inorganic Chemicals
- VHI · VALHI INC /DE/Industrial Inorganic Chemicals
- TXG · 10x Genomics, Inc.Laboratory Analytical Instruments
- FDMT · 4D Molecular Therapeutics, Inc.Biological Products, (No Diagnostic Substances)
LTBR SEC filings: frequently asked questions
Are LTBR insiders buying or selling?
In the last 90 days, LIGHTBRIDGE Corp (LTBR) officers, directors and 10% owners reported no open-market purchases and 2 open-market sales worth $12,347 by 2 insiders on Form 4. Many insider sales are pre-planned or for taxes, so purchases usually carry more information.
Which institutions hold LTBR stock?
As of September 30, 2026, the largest LIGHTBRIDGE Corp (LTBR) holders among the 13F filers tracked by SignalX were BlackRock ($16.0 million), Vanguard Capital Management LLC ($9.4 million), Millennium Management ($6.2 million), State Street Corp ($4.6 million), Renaissance Technologies LLC ($2.9 million). 13F-HR reports are filed up to 45 days after each quarter ends.
What was LTBR's revenue in fiscal year 2025?
For the fiscal year ended December 31, 2025 (FY2025), LIGHTBRIDGE Corp (LTBR) reported revenue of $0 and a net loss of $19.6 million. The figures come from the XBRL data in the 10-K.
What did LTBR report in its latest 8-K?
LIGHTBRIDGE Corp (LTBR) filed an 8-K on November 2, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Press release covers Lightbridge’s quarter ended September 30, 2026.
What are the latest LTBR SEC filings?
LIGHTBRIDGE Corp (LTBR) filed its latest 10-K annual report on February 26, 2026, a 10-Q quarterly report on November 4, 2026, an 8-K current report on November 2, 2026 and a Form 4 insider filing on November 20, 2026.
What is LTBR's SEC CIK number?
LIGHTBRIDGE Corp (LTBR)'s SEC Central Index Key (CIK) is 1084554. EDGAR lists every LTBR filing under that number.
Ask anything about LTBR
The research agent reads LTBR's filings, financials, insider trades and 13F holders, then answers with sources.